ImmunoPrecise Antibodies Ltd. logo
ImmunoPrecise Antibodies Ltd. IPA
$ 0.44 0.0%

Annual report 2022
added 07-29-2022

report update icon

ImmunoPrecise Antibodies Ltd. Income Statement 2011-2024 | IPA

Annual Income Statement ImmunoPrecise Antibodies Ltd.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

78.8 M 82.4 M - - - - - - - - - -

Shares

19.7 M 16.5 M - - - - - - - - - -

Historical Prices

4.13 5.36 14.9 2.2 2.56 2.33 0.005 0.015 0.315 0.09 0.3 1.06

Net Income

-16.7 M -7.34 M -4.95 M -7.62 M -5.17 M -5.38 M 151 K -31.9 K -62.3 K 69.4 K -95.8 K -276 K

Revenue

19.4 M 17.9 M 14.1 M 10.9 M 5.44 M 2.63 M 1.9 M - - - - -

Cost of Revenue

8.38 M 6.37 M 6.02 M - - - - - - - - -

Gross Profit

11 M 11.5 M 8.03 M 5.29 M 2.45 M - - - - - - -

Operating Income

- - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - -

EBITDA

- - -1.47 M -4.35 M -4.53 M -1.29 M 277 K -31 K -64.8 K -96 K -79.9 K -206 K

Operating Expenses

- - 12.1 M 11.5 M 7.21 M - - - - - - -

General and Administrative Expenses

1.16 M 1.44 M 8.6 M 8.3 M 6.31 M 2.82 M 997 K 31 K 64.8 K 94.7 K 79.9 K 206 K

All numbers in CAD currency

Quarterly Income Statement ImmunoPrecise Antibodies Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in CAD currency